Downregulation of wild-type p53 protein by HER-2/neu mediated PI3K pathway activation in human breast cancer cells: its effect on cell proliferation and implication for therapy.
about
A computational strategy to select optimized protein targets for drug development toward the control of cancer diseasesHER2 in Breast Cancer Stemness: A Negative Feedback Loop towards Trastuzumab Resistance.Sphingosine kinase 1 induces tolerance to human epidermal growth factor receptor 2 and prevents formation of a migratory phenotype in response to sphingosine 1-phosphate in estrogen receptor-positive breast cancer cells.Sphingosine 1-phosphate receptor 4 uses HER2 (ERBB2) to regulate extracellular signal regulated kinase-1/2 in MDA-MB-453 breast cancer cellsGreen tea polyphenols induce p53-dependent and p53-independent apoptosis in prostate cancer cells through two distinct mechanismsContext-dependent bidirectional regulation of the MutS homolog 2 by transforming growth factor β contributes to chemoresistance in breast cancer cells.Inhibition of Cell Growth and Induction of Apoptosis by Antrodia camphorata in HER-2/neu-Overexpressing Breast Cancer Cells through the Induction of ROS, Depletion of HER-2/neu, and Disruption of the PI3K/Akt Signaling Pathway.When tumor suppressor TGFβ meets the HER2 (ERBB2) oncogene.Lipid-functionalized dextran nanosystems to overcome multidrug resistance in cancer: a pilot studyThe cholesterol metabolite 27-hydroxycholesterol regulates p53 activity and increases cell proliferation via MDM2 in breast cancer cells.Portraying breast cancers with long noncoding RNAs.Artonin E induces p53-independent G1 cell cycle arrest and apoptosis through ROS-mediated mitochondrial pathway and livin suppression in MCF-7 cells.PI3K/Akt-mediated regulation of p53 in cancer.Differential Response of Two Human Breast Cancer Cell Lines to the Phenolic Extract from Flaxseed Oil.Inhibition of tumor promoting signals by activation of SSTR2 and opioid receptors in human breast cancer cells.Unique signalling connectivity of FGFR3-TACC3 oncoprotein revealed by quantitative phosphoproteomics and differential network analysis.NVP-BEZ235 synergizes cisplatin sensitivity in osteosarcoma.p53 and metabolism: from mechanism to therapeutics.Glioma in Schizophrenia: Is the Risk Higher or Lower?
P2860
Q28543105-9CDABD86-5016-475C-B8F5-6ED5C8CD0F2EQ33737278-8244D20D-CA82-4961-9E02-D49798413E8BQ34045675-E4802CFB-5EC0-4FD7-A440-CAD467BA0211Q34285380-2DAD4997-4F67-4C34-B93E-D143818768CEQ34534169-2A280ECC-F547-4FD0-8EBD-528BE4974B94Q34688096-CB2E57F4-B5E3-45D7-A3F8-299877DCFE05Q36022060-4CAB34EF-B558-4F06-AA80-B0891BC819A9Q36098453-55E45B09-0E5E-4AB9-A772-902DB5B15DE6Q36585890-D9037F2F-09C7-4739-80F6-51F0F96184D9Q36766027-8FD2AD5A-0B89-4538-874E-E2595114B6CBQ37230214-8EE85DA4-38DD-4B05-A98D-6E9DC3DC534BQ37722955-B11BC692-4DE8-4EE5-B430-65192C7EEF7EQ38238609-E0AFEB30-5B4F-4CB3-8C39-D6E2D1425A8DQ38784007-A858C778-8CC0-4D5E-A3D8-95203B6B8C64Q42842968-EE4E3F1A-2055-49AD-8AD2-718C32CF4855Q47149560-13859FD6-F6B9-4E0F-808E-3007DEDB509BQ52657087-9228493A-38C2-4E4A-9216-178ADED4B3E6Q55002919-292DCAA7-D1E6-489C-A742-02F555189EAAQ58767549-E08F172B-06F3-4B8D-AF7F-82B4162FA3D7
P2860
Downregulation of wild-type p53 protein by HER-2/neu mediated PI3K pathway activation in human breast cancer cells: its effect on cell proliferation and implication for therapy.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh
2004年學術文章
@zh-hant
name
Downregulation of wild-type p5 ...... n and implication for therapy.
@en
type
label
Downregulation of wild-type p5 ...... n and implication for therapy.
@en
prefLabel
Downregulation of wild-type p5 ...... n and implication for therapy.
@en
P2093
P2860
P356
P1433
P1476
Downregulation of wild-type p5 ...... n and implication for therapy.
@en
P2093
Hong Guang Zhu
Jia Qiang Ren
Zhao Lu Kong
P2860
P2888
P304
P356
10.1038/SJ.CR.7290253
P577
2004-12-01T00:00:00Z
P5875
P6179
1016039191